Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Ipilimumab-induced sarcoidosis in a patient with metastatic melanoma undergoing complete remission.

Literature DB >> 22124094

Ipilimumab-induced sarcoidosis in a patient with metastatic melanoma undergoing complete remission.

Wouter V Vogel¹, Aurelie Guislain, Pia Kvistborg, Ton N M Schumacher, John B A G Haanen, Christian U Blank.

Abstract

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 2011 PMID： 22124094 DOI： 10.1200/JCO.2011.37.9693

Source DB: PubMed Journal: J Clin Oncol ISSN： 0732-183X Impact factor: 44.544

Keyword Cloud
Cited

× No keyword cloud information.

36 in total

Review 1. Biological agents in gastrointestinal cancers: adverse effects and their management.

Authors: Nivedita Arora; Arjun Gupta; Preet Paul Singh
Journal: J Gastrointest Oncol Date: 2017-06

2. Ipilimumab (yervoy) prolongs survival in advanced melanoma: serious side effects and a hefty price tag may limit its use.

Authors: Chris Fellner
Journal: P T Date: 2012-09

3. Evaluation of response to immunotherapy: new challenges and opportunities for PET imaging.

Authors: Laura Gilardi; Chiara Maria Grana; Giovanni Paganelli
Journal: Eur J Nucl Med Mol Imaging Date: 2014-07-11 Impact factor: 9.236

Review 4. Managing the skin toxicities from new melanoma drugs.

Authors: John C Mavropoulos; Timothy S Wang
Journal: Curr Treat Options Oncol Date: 2014-06

5. Evaluating for Pseudoprogression in Colorectal and Pancreatic Tumors Treated With Immunotherapy.

Authors: Christine M Parseghian; Madhavi Patnana; Priya Bhosale; Kenneth R Hess; Ya-Chen Tina Shih; Bumyang Kim; Scott Kopetz; Michael J Overman; Gauri R Varadhachary; Milind Javle; Aung Naing; Sarina Piha-Paul; David Hong; Hung Le; Vivek Subbiah; Shubham Pant
Journal: J Immunother Date: 2018 Jul/Aug Impact factor: 4.456

Review 6. Immune-mediated adverse events of anticytotoxic T lymphocyte-associated antigen 4 antibody therapy in metastatic melanoma.

Authors: Shannon K Quirk; Anna K Shure; Devendra K Agrawal
Journal: Transl Res Date: 2015-06-11 Impact factor: 7.012

7. Late development of splenic sarcoidosis-like lesions in a patient with metastatic melanoma and long-lasting clinical response to ipilimumab.

Authors: Rikke Andersen; Peter Nørgaard; Mohamad Kadhem Mohamad Al-Jailawi; Inge Marie Svane
Journal: Oncoimmunology Date: 2014-08-03 Impact factor: 8.110